Myriad Genetics (MYGN) Earnings Date, Estimates & Call Transcripts → Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad) Free MYGN Stock Alerts $18.64 -0.28 (-1.48%) (As of 04/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 1EstimatedActual EPS (Feb. 27) $0.04 Beat By $0.03 Consensus EPS (Feb. 27) $0.01 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Myriad Genetics Earnings AlertsEnter your email address below to receive the latest news and earnings results for MYGN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMYGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MYGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Myriad Genetics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.15)($0.13)($0.14) Q2 20242($0.07)($0.06)($0.07) Q3 20242($0.07)($0.06)($0.07) Q4 20242($0.04)($0.02)($0.03) FY 20248($0.33)($0.27) ($0.30)MYGN Earnings Date and InformationMyriad Genetics last released its quarterly earnings results on February 27th, 2024. The reported $0.04 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.03. The firm had revenue of $196.60 million for the quarter, compared to analysts' expectations of $194.80 million. Its revenue for the quarter was up 10.6% compared to the same quarter last year. Myriad Genetics has generated ($3.20) earnings per share over the last year (($3.20) diluted earnings per share). Earnings for Myriad Genetics are expected to grow in the coming year, from ($0.36) to ($0.08) per share. Myriad Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.Read More Myriad Genetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Estimated)------- 2/27/2024Q4 2023$0.01$0.04+$0.03$0.22$194.80 million$196.60 million 11/6/2023Q3 2023($0.08)($0.03)+$0.05$0.41$179.23 million$191.90 million 8/3/2023Q2 2023($0.08)($0.08)-$1.00$187.16 million$183.50 million 5/3/2023Q1 2023($0.19)($0.21)($0.02)$0.11$171.56 million$181.20 million 2/28/2023Q4 2022($0.27)($0.20)+$0.07$0.12$169.16 million$177.80 million11/1/2022Q3 2022($0.15)($0.27)($0.12)($0.11)$172.12 million$156.40 million Get the Latest News and Ratings for MYGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Myriad Genetics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.09)($0.06)+$0.03$0.06$170.05 million$179.30 million 5/5/2022Q1 2022($0.15)($0.14)+$0.01($0.02)$156.09 million$164.90 million 2/24/2022Q4 2021($0.15)($0.11)+$0.04($0.12)$162.21 million$160.80 million 11/2/2021Q3 2021($0.02)($0.02)-($0.54)$164.35 million$167.30 million 8/3/2021Q2 2021($0.09)$0.12+$0.21$0.12$163.09 million$189.40 million 5/2/2021Q1 2021($0.15)($0.06)+$0.09$0.20$155.36 million$173.10 million Myriad Genetics Earnings - Frequently Asked Questions When is Myriad Genetics's earnings date? Myriad Genetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on MYGN's earnings history. Did Myriad Genetics beat their earnings estimates last quarter? In the previous quarter, Myriad Genetics (NASDAQ:MYGN) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.03. Learn more on analysts' earnings estimate vs. MYGN's actual earnings. How can I listen to Myriad Genetics's earnings conference call? The conference call for Myriad Genetics's latest earnings report can be listened to online. Listen to Conference Call How can I read Myriad Genetics's conference call transcript? The conference call transcript for Myriad Genetics's latest earnings report can be read online. Read Transcript How can I view Myriad Genetics's earnings report? Myriad Genetics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Myriad Genetics generate each year? Myriad Genetics (NASDAQ:MYGN) has a recorded annual revenue of $753.20 million. How much profit does Myriad Genetics generate each year? Myriad Genetics (NASDAQ:MYGN) has a recorded net income of -$263.30 million. MYGN has generated -$3.20 earnings per share over the last four quarters. What is Myriad Genetics's EPS forecast for next year? Myriad Genetics's earnings are expected to grow from ($0.36) per share to ($0.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Celldex Therapeutics Earnings Date Intellia Therapeutics Earnings Date Neogen Earnings Date QuidelOrtho Earnings Date Lantheus Earnings Date Catalyst Pharmaceuticals Earnings Date NeoGenomics Earnings Date Geron Earnings Date Structure Therapeutics Earnings Date Fusion Pharmaceuticals Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings call This page (NASDAQ:MYGN) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBiden out June 13; Kamala won’t replace him?Paradigm PressOptions trading has suddenly become more reliable.Eagle PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.